SEATTLE, May 10, 2021, (MEDGADGET) — Medical Nitrous Oxide Delivery Systems Market
Nitrous oxide is a colourless gas or a liquefied compressed gas. It is popularly known as laughing gas. It has a somewhat sweetish taste and a pleasant smell. It is somewhat dissolvable in water and discovered normally all around in the air as a feature of the world’s ordinary nitrogen cycle. Nitrous oxide is broadly utilized in clinical and non-clinical applications. In the clinical business, it is generally utilized in a medical procedure and dentistry techniques as a pain-relieving and sedative.
*The Download PDF brochure only consist of Table of Content, Research Framework, and Research Methodology.
Request PDF Research Report Brochure @ https://www.coherentmarketinsights.com/insight/request-pdf/4247
Inhaled nitric oxide gas and BCG immunotherapy has proved effective in the treatment of Covid-19. Nitric oxide can be used in emergency situations for the treatment of COVID–19 as inhalation of nitric oxide helps improve lung oxygenation. NO also has antiviral properties.
Prominent applications in medical field and increased investment by various companies dealing with medicinal gases is expected to propel the growth of nitrous oxide delivery systems market. For instance, according to Gas World, in 2013 the new SEDARA gas mixer system from Linde Therapeutic Solutions is a fixed-concentration of nitrous oxide delivery systems/oxygen (N2O/O2) therapy innovation in over 20 years.
Stringent rules and regulation over the possession, transport and use of nitrous oxide is expected to hamper growth of nitrous oxide delivery systems market.
Skin allergies caused to health workers who are exposed to the gas is also expected to hinder the growth of nitrous oxide delivery systems market over the forecast period. For instance, according to the United States Environmental Protection Agency, in 2018, nitrous oxide delivery systems (N2O) accounted for about 6.5% of all U.S. greenhouse gas emissions from human activities such as agriculture, fuel combustion, wastewater management, and industrial processes (medical and non-medical) which increasing the amount of N2O in the atmosphere.
Access research reports that are tailored specifically for you and your organization in order to explore practical growth strategies and recommendations
Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/4247
Nitrous oxide delivery systems market by type is segmented into:
- Gas Canisters
- Obstetric Use
- Dental Use
- Emergency Use
- Anaesthetic Use
- Recreational Use
By End User:
- Dental Clinics
- Ambulatory Surgical Centres
- North America
- Latin America
- Asia Pacific
- Middle East
We value your investment and offer customization as per your requirements.
Share your precise requirements @ https://www.coherentmarketinsights.com/insight/request-customization/4247
North America is expected to witness significant growth in nitrous oxide delivery systems market owing to investments in research and development. For instance, the U.S. National Library of Medicine in 2016 stated that the New York City Health and Hospitals Corporation completed clinical trial on high-concentration continuous flow nitrous oxide delivery systems use for procedure-induced pain or anxiety during dentistry and surgery procedures. Key players in the region are Praxair Technology, Inc. and Matheson Tri-Gas, Inc.
Moreover, Europe is also expected to witness significant growth in nitrous oxide delivery systems market. Growth in this region is driven by growing prevalence of heart disease, pulmonary disease, and diabetes. For instance, according to the EU Clinical Trial Register, in 2016, Air Liquide Santé International initiated the study of equimolar mixture of oxygen and nitrous oxide delivery systems (EMONO) for the treatment of peripheral neuropathic pain, a randomised, international, multicentre, placebo–controlled, phenotype–stratified and completed its phase IIa. Key players in the region are Air Liquide S.A, SOL SpA, and Merck KGaA.
Asia-Pacific is also expected to witness significant growth further owing to wide applications of nitrous oxide delivery systems in medical and non-medical industries. Asia Pacific is home to industries in various sectors such as electronics, pharmaceutical. In 2015, The Messer Group GmbH, a supplier of industrial gases, commissioned its new US$ 37.41 million, specialty gas plant in Suzhou, eastern China.Key players in region are Taiyo Nippon Sanso Corporation, Promas Engineers Pvt. Ltd, and S.S. Gas Lab Asia Pvt. Ltd.
Key players involved in nitrous oxide delivery systems are Taiyo Nippon Sanso Corporation, Promas Engineers Pvt. Ltd, S.S. Gas Lab Asia Pvt. Ltd, Praxair Technology, Inc, Matheson Tri–Gas, Inc, Air Liquide S.A, SOL SpA, Merck KGaA, Linde plc, Oxygen & Argon Works Ltd, and Bellerophon Therapeutics.
To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/medical-nitrous-oxide-delivery-systems-market-4247
- In 2018, African Oxygen Limited (Afrox) signed a new state healthcare contract from October 2017 to September 2022 , the healthcare contract includes providing the supply of a range of medical and other gases including oxygen, nitrogen, nitrous oxide delivery systems, carbon dioxide, hydrogen, helium, argon, gas mixtures and refrigeration gases, besides others across South Africa. Moreover, contract also specified that, Afrox will supply range of medicinal and other gases to more than 400 hospitals and 1600 clinics across South Africa.
- In January 2020, Shanghai Showa Electronics Materials’ new facility which is to be built adjacent to its current factory, will produce high purity nitrous oxide delivery systems and high purity octafluorocyclobutane gases. The factor is expected to start operations in the second half of 2021.
- In March 2020, U.S. Food Drug Administration (FDA) granted emergency expanded access to ‘Bellerophon Therapeutics’ inhaled nitric oxide delivery system for treating the novel coronavirus.
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
To know more about us, please visit our website – www.coherentmarketinsights.com
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027